Attempts to produce a vaccine to protect against Chlamydia trachomatis-induced trachoma
were initiated more than 100 years ago and continued for several decades. Using whole …

Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …

Chlamydiosis is a significant disease affecting Eastern Australian koala (Phascolarctos
cinereus) populations, impacting individual animal welfare and fecundity and therefore …

Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection globally.
Antibiotic treatment is highly effective, but infection is often asymptomatic resulting in most …

Background Resident memory T cells have emerged as key players in the immune response
generated against a number of pathogens. Their ability to take residence in non-lymphoid …

Male chlamydial infection has been understudied despite male and female infections
occurring at similar rates. This is particularly true of asymptomatic infections, which occur in …

Arthropod-borne viruses (arboviruses) are resurging across the globe. Zika virus (ZIKV) has
caused significant concern in recent years because it can lead to congenital malformations …

Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. A licensed vaccine is not yet available, but the first vaccines have …

It is of international priority to develop a vaccine against sexually transmitted Chlamydia
trachomatis infections to combat the continued global spread of the infection. The optimal …

Ocular and urogenital infections with Chlamydia trachomatis (Ct.) are caused by a range of
different serovars. The first Ct. vaccine in clinical development (CTH522/CAF® 01) induced …